ArticleCureus2026
Chylothorax Secondary to Behçet's Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chylothorax is an uncommon cause of pleural effusion and is most frequently associated with trauma or malignancy. Its occurrence in Behçet's disease (BD) is exceptionally rare and is usually related to extensive central venous thrombosis causing obstruction of the thoracic duct. We report the case of a 35-year-old woman with a five-year history of BD who presented with progressive dyspnea, dry cough, and mild hemoptysis. Chest computed tomography (CT) revealed extensive thrombosis of the superior vena cava extending to both brachiocephalic veins and the right subclavian vein, associated with large bilateral pleural effusions. Diagnostic thoracentesis yielded milky pleural fluid with elevated triglyceride levels, confirming bilateral chylothorax. Other potential causes, including pulmonary embolism, pulmonary artery aneurysm, malignancy, chylopericardium, and chyloperitoneum, were excluded. The patient was treated with therapeutic anticoagulation, high-dose corticosteroids, intravenous cyclophosphamide, repeated therapeutic thoracentesis, and nutritional support with dietary fat restriction. Clinical and radiological outcomes were favorable, with complete resolution of dyspnea and marked regression of the pleural effusions. Chylothorax is a rare but important thoracic manifestation of BD. In patients presenting with unexplained pleural effusion and central venous thrombosis, BD should be considered among the differential diagnoses. Early recognition and prompt immunosuppressive therapy, combined with appropriate management of the pleural effusion, are essential to achieve favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.